With just days to go in the current presidential campaign, a greater focus on improving the nation’s health could be the deciding factor in a close election, argues Professor Michael Sparer.
The pharmaceutical company leader praised AI for boosting productivity, but noted that it’s still “all about the people.”
New research from Professor Boaz Abramson pioneers a method for assessing the impact that mental illness has on GDP, making the case that expanding the availability of treatment services and improving treatment of mental illness, especially in late adolescence, could positively impact the economy.
A new CBS study finds that public pharmacies can unlock a price advantage for the government that significantly outweighs the costs.
New research from CBS Professor Carri Chan demonstrates that algorithms provide an effective method for enhancing how hospitals manage fluctuations in patient volume and demand.
US Senator Bill Cassidy, MD, highlights the need to balance regulation and innovation when it comes to embracing AI in medicine.
Policymakers and international organizations like the United Nations have suspected that local banks play a role in improving healthcare outcomes in developing countries. New research affiliated with the Bernstein Center for Leadership and Ethics takes a broad look at bank services in developing countries and uncovers surprising links between healthcare marketplaces and positive community outcomes.
Columbia Business School research is the first to find empirical evidence for how government intervention would shape the private healthcare market
Professor Carri Chan joined three leaders in the healthcare field at Columbia Business School's Think Bigger Innovation Summit to discuss how they are challenging the boundaries of innovation.
Columbia Business School Research Reveals That Addressing the Psychology of Secrets Can Enhance Emotional Well-Being and Social Connections